-1.png?width=320&name=Intraosseous%20Delivery%20of%20Autologous%20Biologic%20Therapies%20for%20Osteoarthritis%20(3)-1.png)
Wednesday, April 15th @ 5pm PT | 8pm ET
Discover the role of the osteochondral unit in joint pain and why targeting subchondral bone with intraosseous biologic therapies may improve outcomes. This session examines evidence-based intraosseous techniques, emerging clinical data supporting pain relief and joint function, and practical considerations for patient selection, diagnostic imaging, and integration of autologous biologic interventions into practice.
Objectives
Understand the role of the osteochondral unit in joint pain and the rationale for targeting subchondral bone with intraosseous biologic therapies
Explore evidence-based intraosseous biologic techniques and emerging clinical evidence supporting improved pain relief, joint function, and outcomes in osteochondral pathology
Review patient selection, diagnostic imaging, and key clinical considerations when incorporating intraosseous autologous biologic interventions into practice
Featured Presenter
.svg)
Walter Sussman, DO
Dr. Walter Sussman is a board-certified specialist in Physical Medicine & Rehabilitation with fellowship training and board certification in Sports Medicine. He graduated from the University of New England College of Osteopathic Medicine and completed his residency at Emory University, where he served as chief resident. Dr. Sussman went on to complete a Sports Medicine Fellowship at Emory, providing care for the Atlanta Dream WNBA team, Georgia Tech athletics, and Emory University sports. He has served as Head Team Physician for the University of Massachusetts Dartmouth and provides care for local high school athletes.
Dr. Sussman’s clinical interests include ultrasound-guided diagnostics and regenerative medicine. He co-authored The Atlas of Interventional Orthopedics and has published research on ultrasound-guided procedures, nerve hydrodissection, and concussion management. As a leader in regenerative medicine, he serves on the Board of the Interventional Orthobiologics Foundation and is a member of the American Academy of PM&R Biologics Working Group. In 2020, he founded Boston Sports & Biologics to offer non-surgical treatments for musculoskeletal injuries, including PRP, autologous cellular injections, and Tenex. Dr. Sussman is also dedicated to personalized care for conditions such as arthritis, tendonitis, rotator cuff tears, and sports-related concussions.